title: Extended Abstract: Management of Liver Cancer.
abstract: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. HCC represents more than 90% of primary liver cancers. There is a growing incidence of HCC worldwide. In the Western world, HCC arises in a cirrhotic background in up to 90% of cases, and cirrhosis itself is a progressive disease that affects patient survival. Thus, outcome in patients with HCC and the chances for anti-tumor treatment and its results are dependent not only on tumor-associated factors but also on liver function.
authors.affiliation: I. Medical Department, University Medical Center Mainz, Mainz, Germany.
authors.forename: Peter Robert
authors.initials: PR
authors.lastname: Galle
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000503:physiopathology*; D018450:Disease Progression; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology*; D008113:Liver Neoplasms / Q000209:etiology / Q000503:physiopathology*; D017410:Practice Guidelines as Topic